Haemonetics Corporation
US ˙ NYSE ˙ US4050241003

SecurityHAE / Haemonetics Corporation
InstitutionCitadel Advisors Llc
ManagerKen Griffin
Latest Disclosed Ownership258,153 shares
Latest Disclosed Value $ 14,549,503
Citadel Advisors Llc ownership in HAE / Haemonetics Corporation

On May 15, 2026 - Citadel Advisors Llc filed a 13F-HR form disclosing ownership of 258,153 shares of Haemonetics Corporation (US:HAE) valued at $14,549,503 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,288,432 shares of Haemonetics Corporation. This represents a change in shares of -79.96% during the quarter. The current value of the position is $18,401,146 USD.

Citadel Advisors Llc has a history of taking positions in derivatives of the underlying security (HAE) in the form of stock options. The firm currently holds call options representing 16,800 of underlying shares valued at $946,848 USD and put options representing 5,900 of underlying shares valued at $332,524 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

HAE / Haemonetics Corporation Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 258,153 -1,030,279 -79.96 14,550 -85.91 0.0021
2026-02-17 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,288,432 1,067,004 481.87 103,268 856.88 0.0155
2025-11-14 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 221,428 -31,205 -12.35 10,792 -42.74 0.0016
2025-08-14 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 252,633 -105,547 -29.47 18,849 -17.20 0.0033
2025-05-15 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 358,180 168,736 89.07 22,762 53.89 0.0043
2025-02-14 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 189,444 -151,873 -44.50 14,792 -46.09 0.0026
2024-11-14 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 341,317 139,795 69.37 27,435 64.57 0.0053
2024-08-14 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 201,522 183,991 1,049.52 16,672 1,014.37 0.0034
2024-05-15 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 17,531 17,531 1,496 0.0003
2024-02-14 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 0 -1,768 -100.00 0 -100.00
2023-11-14 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,768 77 4.55 158 10.49 0.0000
2023-08-14 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 1,691 -646 -27.64 144 -25.91 0.0000
2023-05-15 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 2,337 -3,225 -57.98 193 -55.84 0.0000
2023-02-14 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 5,562 -2,319 -29.43 437 -25.04 0.0001
2022-11-14 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 7,881 -630,563 -98.77 583 -98.60 0.0001
2022-08-15 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 638,444 638,444 41,614 0.0107
2022-05-16 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 0 -210,575 -100.00 0 -100.00
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 210,575 152,736 264.07 11,168 173.52 0.0023
2021-11-15 2021-09-30 13F HAEMONETICS CORP MASS Cmn 405024100 57,839 -137,639 -70.41 4,083 -68.65 0.0008
2021-08-16 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 195,478 178,953 1,082.92 13,026 610.25 0.0029
2021-05-21 2021-03-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 16,525 -46,020 -73.58 1,834 -75.31 0.0004
2021-05-17 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 16,525 -46,020 1,834 0.0004
2021-02-16 2020-12-31 13F HAEMONETICS COM 405024100 62,545 -29,766 -32.25 7,427 -7.78 0.0019
2020-11-16 2020-09-30 13F HAEMONETICS COM 405024100 92,311 -67,079 -42.08 8,054 -43.58 0.0023
2020-08-14 2020-06-30 13F HAEMONETICS Cmn 405024100 159,390 50,607 46.52 14,275 31.68 0.0051
2020-05-15 2020-03-31 13F HAEMONETICS Cmn 405024100 108,783 -33,752 -23.68 10,841 -33.81 0.0049
2020-02-14 2019-12-31 13F HAEMONETICS Cmn 405024100 142,535 109,217 327.80 16,378 289.67 0.0071
2019-11-14 2019-09-30 13F HAEMONETICS Cmn 405024100 33,318 22,903 219.90 4,203 235.43 0.0020
2019-08-14 2019-06-30 13F HAEMONETICS Cmn 405024100 10,415 -40,399 -79.50 1,253 -71.81 0.0006
2019-05-15 2019-03-31 13F HAEMONETICS Cmn 405024100 50,814 50,814 4,445 0.0022
2019-02-14 2018-12-31 13F HAEMONETICS Cmn 405024100 0 -22,036 -100.00 0 -100.00
2018-11-13 2018-09-30 13F HAEMONETICS Cmn 405024100 22,036 -148,744 -87.10 2,525 -83.51 0.0011
2018-08-14 2018-06-30 13F/A-1 HAEMONETICS Cmn 405024100 170,780 129,362 312.33 15,315 405.45 0.0076
2018-08-10 2018-06-30 13F HAEMONETICS Cmn 405024100 170,780 129,362 15,315
2018-05-14 2018-03-31 13F/A-1 HAEMONETICS Cmn 405024100 41,418 -30,526 -42.43 3,030 -27.49 0.0017
2018-05-11 2018-03-31 13F HAEMONETICS Cmn 405024100 41,418 -30,526 3,030
2018-02-09 2017-12-31 13F HAEMONETICS Cmn 405024100 71,944 55,195 329.54 4,179 514.56 0.0025
2017-05-12 2017-03-31 13F HAEMONETICS Cmn 405024100 16,749 16,749 680 0.0006
2017-02-10 2016-12-31 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 0 -9,820 -100.00 0 -100.00
2017-01-31 2016-09-30 13F/A-1 HAEMONETICS Cmn 405024100 9,820 -120,889 -92.49 356 -90.60 0.0004
2016-11-10 2016-09-30 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 9,820 356
2017-01-31 2016-06-30 13F/A-1 HAEMONETICS Cmn 405024100 130,709 55,468 73.72 3,789 43.96 0.0042
2016-08-12 2016-06-30 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 130,709 3,789
2017-01-31 2016-03-31 13F/A-1 HAEMONETICS Cmn 405024100 75,241 3,371 4.69 2,632 13.60 0.0033
2016-05-13 2016-03-31 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 75,241 2,632
2017-01-31 2015-12-31 13F/A-1 HAEMONETICS Cmn 405024100 71,870 -14,445 -16.74 2,317 -16.95 0.0025
2016-02-12 2015-12-31 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 71,870 2,317
2015-11-16 2015-09-30 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 86,315 33,022 61.96 2,790 26.59 0.0027
2015-08-14 2015-06-30 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 53,293 -2,485 -4.46 2,204 -12.05 0.0019
2015-05-15 2015-03-31 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 55,778 -89,763 -61.68 2,506 -53.98 0.0028
2015-02-17 2014-12-31 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 145,541 -50,643 -25.81 5,446 -20.50 0.0066
2014-11-14 2014-09-30 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 196,184 45,214 29.95 6,850 28.61 0.0086
2014-08-14 2014-06-30 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 150,970 -83,292 -35.56 5,326 -30.23 0.0072
2014-05-15 2014-03-31 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 234,262 222,175 1,838.13 7,634 1,483.82 0.0105
2013-11-14 2013-09-30 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 12,087 -70,039 -85.28 482 -85.81 0.0007
2013-08-14 2013-06-30 13F HAEMONETICS CORPORATION CMN STK Cmn 405024100 82,126 82,126 3,396 0.0059
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F HAEMONETICS CORP MASS COM Call 16,800 28.24 947 -9.82 n/a n/a n/a
2026-02-17 2025-12-31 13F HAEMONETICS CORP MASS COM Call 13,100 -68.88 1,050 -48.85 n/a n/a n/a
2025-11-14 2025-09-30 13F HAEMONETICS CORP MASS COM Call 42,100 -2.09 2,052 -36.07 n/a n/a n/a
2025-08-14 2025-06-30 13F HAEMONETICS CORP MASS COM Call 43,000 -12.24 3,208 3.05 n/a n/a n/a
2025-05-15 2025-03-31 13F HAEMONETICS CORP MASS COM Call 49,000 -11.87 3,114 -28.29 n/a n/a n/a
2025-02-14 2024-12-31 13F HAEMONETICS CORP MASS COM Call 55,600 54.02 4,341 49.64 n/a n/a n/a
2024-11-14 2024-09-30 13F HAEMONETICS CORP MASS COM Call 36,100 53.62 2,902 49.23 n/a n/a n/a
2024-08-14 2024-06-30 13F HAEMONETICS CORP MASS COM Call 23,500 -10.65 1,944 -13.37 n/a n/a n/a
2024-05-15 2024-03-31 13F HAEMONETICS CORP MASS COM Call 26,300 68.59 2,245 68.34 n/a n/a n/a
2024-02-14 2023-12-31 13F HAEMONETICS CORP MASS COM Call 15,600 -32.47 1,334 -35.57 n/a n/a n/a
2023-11-14 2023-09-30 13F HAEMONETICS CORP MASS COM Call 23,100 61.54 2,069 70.01 n/a n/a n/a
2023-08-14 2023-06-30 13F HAEMONETICS CORP MASS COM Call 14,300 -22.28 1,218 -20.04 n/a n/a n/a
2023-05-15 2023-03-31 13F HAEMONETICS CORP MASS COM Call 18,400 201.64 1,523 217.75 n/a n/a n/a
2023-02-14 2022-12-31 13F HAEMONETICS CORP MASS COM Call 6,100 -55.15 480 -52.43 n/a n/a n/a
2022-11-14 2022-09-30 13F HAEMONETICS CORP MASS COM Call 13,600 13.33 1,007 28.77 n/a n/a n/a
2022-08-15 2022-06-30 13F HAEMONETICS CORP MASS COM Call 12,000 -42.58 782 -40.80 n/a n/a n/a
2022-05-16 2022-03-31 13F HAEMONETICS CORP MASS COM Call 20,900 16.11 1,321 38.32 n/a n/a n/a
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM Call 18,000 -47.67 955 -60.67 n/a n/a n/a
2021-11-15 2021-09-30 13F HAEMONETICS CORP MASS Cmn Call 34,400 -10.65 2,428 -5.38 n/a n/a n/a
2021-08-16 2021-06-30 13F HAEMONETICS CORP MASS COM Call 38,500 775.00 2,566 425.82 n/a n/a n/a
2021-05-21 2021-03-31 13F/A HAEMONETICS CORP MASS COM Call 4,400 -32.31 488 -36.79 n/a n/a n/a
2021-05-17 2021-03-31 13F HAEMONETICS CORP MASS COM Call 4,400 488 n/a n/a n/a
2021-02-16 2020-12-31 13F HAEMONETICS COM Call 6,500 4.84 772 42.70 n/a n/a n/a
2020-11-16 2020-09-30 13F HAEMONETICS COM Call 6,200 -33.33 541 -35.05 n/a n/a n/a
2020-08-14 2020-06-30 13F HAEMONETICS Cmn Call 9,300 22.37 833 10.04 n/a n/a n/a
2020-05-15 2020-03-31 13F HAEMONETICS Cmn Call 7,600 322.22 757 265.70 n/a n/a n/a
2020-02-14 2019-12-31 13F HAEMONETICS Cmn Call 1,800 -79.07 207 -80.92 n/a n/a n/a
2019-11-14 2019-09-30 13F HAEMONETICS Cmn Call 8,600 168.75 1,085 181.82 n/a n/a n/a
2019-08-14 2019-06-30 13F HAEMONETICS Cmn Call 3,200 -52.94 385 -35.29 n/a n/a n/a
2019-05-15 2019-03-31 13F HAEMONETICS Cmn Call 6,800 15.25 595 0.85 n/a n/a n/a
2019-02-14 2018-12-31 13F HAEMONETICS Cmn Call 5,900 -64.02 590 -68.60 n/a n/a n/a
2018-11-13 2018-09-30 13F HAEMONETICS Cmn Call 16,400 86.36 1,879 138.15 n/a n/a n/a
2018-08-14 2018-06-30 13F/A HAEMONETICS Cmn Call 8,800 17.33 789 43.72 n/a n/a n/a
2018-08-10 2018-06-30 13F HAEMONETICS Cmn Call 8,800 789 n/a n/a n/a
2018-05-14 2018-03-31 13F/A HAEMONETICS Cmn Call 7,500 97.37 549 148.42 n/a n/a n/a
2018-05-11 2018-03-31 13F HAEMONETICS Cmn Call 7,500 549 n/a n/a n/a
2018-02-09 2017-12-31 13F HAEMONETICS Cmn Call 3,800 221 n/a n/a n/a
2015-11-16 2015-09-30 13F HAEMONETICS CORPORATION CMN STK Cmn Call 0 -100.00 0 -100.00 n/a n/a n/a
2015-08-14 2015-06-30 13F HAEMONETICS CORPORATION CMN STK Cmn Call 4,000 185.71 165 161.90 n/a n/a n/a
2015-05-15 2015-03-31 13F HAEMONETICS CORPORATION CMN STK Cmn Call 1,400 366.67 63 472.73 n/a n/a n/a
2015-02-17 2014-12-31 13F HAEMONETICS CORPORATION CMN STK Cmn Call 300 11 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F HAEMONETICS CORP MASS COM Put 5,900 -22.37 333 -45.48 n/a n/a n/a
2026-02-17 2025-12-31 13F HAEMONETICS CORP MASS COM Put 7,600 -53.66 609 -23.78 n/a n/a n/a
2025-11-14 2025-09-30 13F HAEMONETICS CORP MASS COM Put 16,400 256.52 799 132.94 n/a n/a n/a
2025-08-14 2025-06-30 13F HAEMONETICS CORP MASS COM Put 4,600 -48.31 343 -39.29 n/a n/a n/a
2025-05-15 2025-03-31 13F HAEMONETICS CORP MASS COM Put 8,900 -75.88 566 -80.39 n/a n/a n/a
2025-02-14 2024-12-31 13F HAEMONETICS CORP MASS COM Put 36,900 141.18 2,881 134.42 n/a n/a n/a
2024-11-14 2024-09-30 13F HAEMONETICS CORP MASS COM Put 15,300 66.30 1,230 61.50 n/a n/a n/a
2024-08-14 2024-06-30 13F HAEMONETICS CORP MASS COM Put 9,200 -9.80 761 -12.53 n/a n/a n/a
2024-05-15 2024-03-31 13F HAEMONETICS CORP MASS COM Put 10,200 264.29 871 264.02 n/a n/a n/a
2024-02-14 2023-12-31 13F HAEMONETICS CORP MASS COM Put 2,800 -39.13 239 -41.99 n/a n/a n/a
2023-11-14 2023-09-30 13F HAEMONETICS CORP MASS COM Put 4,600 6.98 412 12.57 n/a n/a n/a
2023-08-14 2023-06-30 13F HAEMONETICS CORP MASS COM Put 4,300 -73.12 366 -72.36 n/a n/a n/a
2023-05-15 2023-03-31 13F HAEMONETICS CORP MASS COM Put 16,000 226.53 1,324 243.90 n/a n/a n/a
2023-02-14 2022-12-31 13F HAEMONETICS CORP MASS COM Put 4,900 28.95 385 37.01 n/a n/a n/a
2022-11-14 2022-09-30 13F HAEMONETICS CORP MASS COM Put 3,800 -56.32 281 -50.44 n/a n/a n/a
2022-08-15 2022-06-30 13F HAEMONETICS CORP MASS COM Put 8,700 -17.92 567 -15.37 n/a n/a n/a
2022-05-16 2022-03-31 13F HAEMONETICS CORP MASS COM Put 10,600 -75.85 670 -71.22 n/a n/a n/a
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM Put 43,900 237.69 2,328 153.59 n/a n/a n/a
2021-11-15 2021-09-30 13F HAEMONETICS CORP MASS Cmn Put 13,000 -52.73 918 -49.92 n/a n/a n/a
2021-08-16 2021-06-30 13F HAEMONETICS CORP MASS COM Put 27,500 216.09 1,833 89.75 n/a n/a n/a
2021-05-21 2021-03-31 13F/A HAEMONETICS CORP MASS COM Put 8,700 -16.35 966 -21.78 n/a n/a n/a
2021-05-17 2021-03-31 13F HAEMONETICS CORP MASS COM Put 8,700 966 n/a n/a n/a
2021-02-16 2020-12-31 13F HAEMONETICS COM Put 10,400 67.74 1,235 128.28 n/a n/a n/a
2020-11-16 2020-09-30 13F HAEMONETICS COM Put 6,200 -7.46 541 -9.83 n/a n/a n/a
2020-08-14 2020-06-30 13F HAEMONETICS Cmn Put 6,700 55.81 600 39.86 n/a n/a n/a
2020-05-15 2020-03-31 13F HAEMONETICS Cmn Put 4,300 429 n/a n/a n/a
2020-02-14 2019-12-31 13F HAEMONETICS Cmn Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-11-14 2019-09-30 13F HAEMONETICS Cmn Put 1,900 -24.00 240 -20.27 n/a n/a n/a
2019-08-14 2019-06-30 13F HAEMONETICS Cmn Put 2,500 4.17 301 43.33 n/a n/a n/a
2019-05-15 2019-03-31 13F HAEMONETICS Cmn Put 2,400 -63.08 210 -67.69 n/a n/a n/a
2019-02-14 2018-12-31 13F HAEMONETICS Cmn Put 6,500 -44.44 650 -51.53 n/a n/a n/a
2018-11-13 2018-09-30 13F HAEMONETICS Cmn Put 11,700 -89.38 1,341 -86.43 n/a n/a n/a
2018-08-14 2018-06-30 13F/A HAEMONETICS Cmn Put 110,200 9,883 n/a n/a n/a
2018-08-10 2018-06-30 13F HAEMONETICS Cmn Put 110,200 9,883 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.